Sign in
Gregg Girvan
@ggirvan
Foundation for Research on Equal Opportunity
Projects
Inflation by Category 2000—
24 days ago • published
WIHI World 2020
3 months ago • published
WIHI World 2021
3 months ago • published
Hospital concentration: TN
4 months ago • published
2026-35 ESI Hospital Paper
7 months ago • published
ESI Hospital Paper Summary (Stacked colums)
7 months ago • published
ESI Hospital Paper Summary
7 months ago • published
Copy of Emerging Pharma Outperforms Larger Firms
9 months ago • published
Emerging Company Share of Drug Innovation 2013-22
9 months ago • published
Inflation Values by Drug Company Size
9 months ago • published
Copy of Emerging Discoverers and Marketers 2013-22
9 months ago • published
Emerging Discoverers and Marketers 2013-22
9 months ago • published
Emerging Pharma Outperforms Larger Firms
9 months ago • published
International Drug Spending
9 months ago • published
Large Pharma Company Revenue and R&D vs. Rest of the Industry
a year ago • published
Relative price of health care, 2020
a year ago • published
U.S. Hospital Spend as % of Income
a year ago • published
WIHI 2022 Hospital Spending
a year ago • published
WIHI Inpatient Spend Table
a year ago • published
2026 IRA Drug List (Net)
a year ago • published
2026 IRA Drug List, ranked by savings
a year ago • published
2026 IRA Drug List (Gross)
a year ago • published
Health Expenditure % GDP
a year ago • published
FCA Coverage in 2030
a year ago • published
FCA Coverage in 2030
a year ago • published
2026 IRA Drug List
a year ago • published
2026 IRA Top 10 drugs
a year ago • published
WIHI inpatient spend % vs cardio care
a year ago • published
WIHI inpatient spend vs cardio care, No Outliers
a year ago • published
WIHI inpatient spend % vs cardio care, no outliers
a year ago • published
WIHI inpatient spend vs cardio care
a year ago • published
WIHI Inpatient Spending Table
a year ago • published
WIHI inpatient spend vs cardio care (no outliers)
a year ago • published
WIHI Inpatient Spending vs Overall Quality
a year ago • published
VHA Reform Fiscal Projections
a year ago • published
Increase in Biologics vs. Small Molecules v2
a year ago • published
Biologics vs. Small Molecules v2
a year ago • published
VetsCare Financial Projections
a year ago • published
Bar chart 2026 top 10 IRA drugs
2 years ago • published
WIHI Rankings 2022
2 years ago • published
2022 WIHI Components of Transparency
2 years ago • published
WIHI World 2022
2 years ago • published
2022 WIHI Dimensions
2 years ago • published
2022 WIHI Australia
2 years ago • published
2022 WIHI Saudi Arabia
2 years ago • published
2022 WIHI Greece
2 years ago • published
2022 WIHI Canada
2 years ago • published
2022 WIHI Hungary
2 years ago • published
2022 WIHI South Korea
2 years ago • published
2022 WIHI Norway
2 years ago • published
2022 WIHI Italy
2 years ago • published
2022 WIHI New Zealand
2 years ago • published
2022 WIHI Spain
2 years ago • published
2022 WIHI Sweden
2 years ago • published
2022 WIHI United Kingdom
2 years ago • published
2022 WIHI Finland
2 years ago • published
2022 WIHI Portugal
2 years ago • published
2022 WIHI Slovakia
2 years ago • published
2022 WIHI United States
2 years ago • published
2022 WIHI United Arab Emirates
2 years ago • published
2022 WIHI Austria
2 years ago • published
2022 WIHI Switzerland
2 years ago • published
2022 WIHI Germany
2 years ago • published
2022 WIHI Ireland
2 years ago • published
2022 WIHI Netherlands
2 years ago • published
2022 WIHI Israel
2 years ago • published
2022 WIHI Belgium
2 years ago • published
2022 WIHI Czech Republic
2 years ago • published
2022 WIHI Japan
2 years ago • published
2022 WIHI Denmark
2 years ago • published
2022 WIHI France
2 years ago • published
2022 WIHI Hong Kong
2 years ago • published
2022 WIHI Poland
2 years ago • published
2022 WIHI Singapore
2 years ago • published
2022 WIHI Taiwan
2 years ago • published
2022 WIHI Europe
2 years ago • published
2022 WIHI East Asia
2 years ago • published
2022 WIHI Oceania
2 years ago • published
2022 WIHI North America
2 years ago • published
2022 WIHI West Asia
2 years ago • published
Federal Spending on Welfare, 2008-20
2 years ago • published
2021 WIHI Finland
2 years ago • published
2021 WIHI Dimensions
2 years ago • published
2021 WIHI East Asia
2 years ago • published
2021 WIHI Europe
2 years ago • published
Xeljanz Net Price Changes
2 years ago • published
Final Impact of Price Reductions on Drugs Developed
2 years ago • published
Drug Companies by Price-driven revenue
2 years ago • published
Selected Drugs
2 years ago • published
Drug Company Cards
2 years ago • published
Stelara Net Price Changes
2 years ago • published
Gilenya Net Price Changes
2 years ago • published
Humira Net Price Changes
2 years ago • published
Aubagio Net Price Changes
2 years ago • published
Benlysta Net Price Changes
2 years ago • published
Orencia Net Price Changes
2 years ago • published
Entyvio Net Price Changes
2 years ago • published
Alimta Net Price Changes
2 years ago • published
Avastin Net Price Changes
2 years ago • published
Truvada Net Price Changes
2 years ago • published
Victoza Net Price Changes
2 years ago • published
Xtandi Net Price Changes
2 years ago • published
Tysabri Net Price Changes
2 years ago • published
Lynparza Net Price Changes
2 years ago • published
Enbrel Net Price Changes
2 years ago • published
Keytruda Net Price Changes
2 years ago • published
Copy of Price-driven Revenue vs R&D decrement
2 years ago • published
Price-driven Revenue vs R&D decrement
2 years ago • published
Company R&D Spending per New Drug
2 years ago • published
Drug Counting Methodology
2 years ago • published
Emerging Pipeline
2 years ago • published
Large Pharma Company Revenue and R&D vs. Rest of Industry
2 years ago • published
Rx Volume vs. Net Spending
2 years ago • published
Lynparza Revenue Analysis, 2016-2021
2 years ago • published
Keytruda Revenue Analysis, 2016-2021
2 years ago • published
Alimta Revenue Analysis, 2012-2021
2 years ago • published
Entyvio Revenue Analysis, 2016-2021
2 years ago • published
Benlysta Revenue Analysis, 2013-2021
2 years ago • published
Aubagio Revenue Analysis, 2014-2021
2 years ago • published
Orencia Revenue Analysis, 2012-2021
2 years ago • published
Stelara Revenue Analysis, 2012-2021
2 years ago • published
Gilenya Revenue Analysis, 2012-2021
2 years ago • published
Humira Revenue Analysis, 2012-2021
2 years ago • published
Xeljanz Revenue Analysis, 2014-2021
2 years ago • published
Truvada Revenue Analysis, 2012-2021
2 years ago • published
Victoza Revenue Analysis, 2012-2021
2 years ago • published
Avastin Revenue Analysis, 2012-2021
2 years ago • published
Xtandi Revenue Analysis, 2014-2021
2 years ago • published
Tysabri Revenue Analysis, 2012-2021
2 years ago • published
Enbrel Revenue Analysis, 2012-2021
2 years ago • published
Revenue and R&D Results
2 years ago • published
Drug Price Increase Inefficiency
2 years ago • published
Company R&D Spending per New Drug
2 years ago • published
Startup Share of Drug Innovation 2012-21
2 years ago • published
Humira Revenue Analysis
2 years ago • published
FCA vs Biden Family Glitch fixes
3 years ago • published
Urban vs. Biden Effects of Family Glitch Fix
3 years ago • published
Family members with Unaffordable Coverage
3 years ago • published
Coverage changes following family glitch fix
3 years ago • published
Top 10 Drugs by Medicaid Net Spending, incl. Aduhelm
3 years ago • published
Clinical Trial Comparison, Placebo effects
3 years ago • published
FDA Approvals for Alzheimer's
3 years ago • published
Top 10 Drugs by Medicaid Net Spending, incl. Aduhelm
3 years ago • published
Dangling Accelerated Approvals, >5 years
3 years ago • published
Aduhelm Clinical Trial Comparison, ENGAGE study protocols
3 years ago • published
Aduhelm Clinical Trial Comparison, high-dose protocol
3 years ago • published
Aduhelm Clinical Trial Comparison, original protocol
3 years ago • published
Aduhelm Clinical Trial Comparison
3 years ago • published
Albert Lea Hospital Closure impact on ALFs
3 years ago • published
COVID-19 Hospitalizations and Deaths
3 years ago • published
ALFs near Rural Hospital Closures
3 years ago • published
Nursing Homes near Rural Hospital Closures
3 years ago • published
Copy of Nursing Home v Working Age Death Rate
3 years ago • published
Rural Hospital Closures near ALFs w/ All Hospitals
3 years ago • published
Rural Hospital Closures and ALFs
3 years ago • published
Orphan Drugs in Phase III
3 years ago • published
Unprofitable Originators %
3 years ago • published
Humira Revenue Growth Drivers (Quarterly)
3 years ago • published
Advair Revenue Growth Drivers (Annual)
3 years ago • published
Remicade Revenue Growth Drivers (Annual)
3 years ago • published
Copy of Humira Revenue Growth Drivers
3 years ago • published
Remicade Revenue Growth Drivers
3 years ago • published
Humira Revenue Growth Drivers
3 years ago • published
Advair Net Pricing 2011-2020
3 years ago • published
Remicade Net Pricing 2011-2020
3 years ago • published
Humira Net Pricing 2011-2020
3 years ago • published
U.S.-based Clinical Trials (by Prevalence of Condition Treated)
3 years ago • published
Copy of Drugs Developed by Unprofitable Innovators
3 years ago • published
Drugs Developed by Unprofitable Innovators
3 years ago • published
Nursing Home v Working Age Death Rate
3 years ago • published
COVID NH Cases/Deaths 5/9/21 thr 8/29/21
3 years ago • published
2021 WIHI Netherlands
3 years ago • published
WIHI Pandemic Rankings 5/21
3 years ago • published
WIHI 2020 Quality
3 years ago • published
WIHI 2021 Quality
3 years ago • published
WIHI Rankings 2021
3 years ago • published
2021 WIHI Greece
3 years ago • published
2021 WIHI Canada
3 years ago • published
2021 WIHI North America
3 years ago • published
2021 WIHI Oceania
3 years ago • published
2021 WIHI West Asia
3 years ago • published
2021 WIHI Japan
3 years ago • published
2021 WIHI Germany
3 years ago • published
2021 WIHI Australia
3 years ago • published
2021 WIHI Hungary
3 years ago • published
2021 WIHI Italy
3 years ago • published
2021 WIHI South Korea
3 years ago • published
2021 WIHI Norway
3 years ago • published
2021 WIHI New Zealand
3 years ago • published
2021 WIHI Spain
3 years ago • published
2021 WIHI Sweden
3 years ago • published
2021 WIHI United Kingdom
3 years ago • published
2021 WIHI Austria
3 years ago • published
2021 WIHI Belgium
3 years ago • published
2021 WIHI Czech Republic
3 years ago • published
2021 WIHI Denmark
3 years ago • published
2021 WIHI France
3 years ago • published
2021 WIHI Ireland
3 years ago • published
2021 WIHI Israel
3 years ago • published
2021 WIHI Poland
3 years ago • published
2021 WIHI Portugal
3 years ago • published
2021 WIHI Singapore
3 years ago • published
2021 WIHI Slovakia
3 years ago • published
2021 WIHI Switzerland
3 years ago • published
2021 WIHI Taiwan
3 years ago • published
2021 WIHI Hong Kong
3 years ago • published
2021 WIHI United States
3 years ago • published
2021 WIHI United Arab Emirates
3 years ago • published
State-by-state nursing home scatterplot
4 years ago • published
NY Hospital Death Comparison (single chart)
4 years ago • published
NY Nursing Home Deaths In vs. Out of Facility
4 years ago • published
New York Comparison (after data correction)
4 years ago • published
COVID-19 Fatality Rate of LTC Residents
4 years ago • published
New York Comparison (before data correction)
4 years ago • published
Copy of LTC Share of U.S COVID-19 Fatalities
4 years ago • published
International LTC COVID-19 Deaths (Donut)
4 years ago • published
LTC COVID-19 Fatalities Pop-Adj. 2020-12-20
4 years ago • published
LTC Share of U.S COVID-19 Fatalities
4 years ago • published
LTC Share of U.S COVID-19 Fatalities
4 years ago • published
COVID-19 Fatality Rate of LTC Residents
4 years ago • published
2020-06-27 LTC Share of U.S COVID-19 Fatalities
4 years ago • published
COVID-19 Fatality Rate of LTC Residents
4 years ago • published
LTC Share of U.S COVID-19 Fatalities
4 years ago • published
Templates
This user has no templates that you can view
